{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Peapack",
      "address_1": "100 North Route 206",
      "reason_for_recall": "Failed Dissolution Specifications: Dissolution at 8 hour was out of specification at 12 month at 25 degree Celsius.",
      "address_2": "",
      "product_quantity": "9,666 units",
      "code_info": "Lot #: 03216025A, Exp.01/18.",
      "center_classification_date": "20170322",
      "distribution_pattern": "Nationwide within US",
      "state": "NJ",
      "product_description": "Quillivant XR (methylphenidate HCl) for extended-release oral suspension, 900 mg/180 mL (25mg/5mL), Rx Only, Distributed by: NextWave Pharmaceuticals, Inc. A subsidiary of Pfizer Inc, New York, NY 10017  Manufactured by: Tris Pharma, Inc., Monmouth Junction, NJ 08852 (NDC 24478-190-30).",
      "report_date": "20170329",
      "classification": "Class III",
      "openfda": {},
      "recalling_firm": "Pfizer Inc",
      "recall_number": "D-0609-2017",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "76663",
      "termination_date": "20190531",
      "more_code_info": "",
      "recall_initiation_date": "20170307",
      "postal_code": "07977",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}